Treatment of vascular graft infections: gentamicin-coated ePTFE grafts reveals strong antibacterial properties in vitro

[1]  P. Kolh,et al.  Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections , 2020 .

[2]  L. Bordenave,et al.  In vitro Evidence of Improved Antimicrobial Efficacy of Silver and Triclosan Containing Vascular Grafts Compared with Rifampicin Soaked Grafts. , 2019, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[3]  J. Daurès,et al.  A Meta-Analysis of Outcomes After In Situ Reconstructions for Aortic Graft Infection , 2018, Angiology.

[4]  R. Burgkart,et al.  Viable adhered Staphylococcus aureus highly reduced on novel antimicrobial sutures using chlorhexidine and octenidine to avoid surgical site infection (SSI) , 2018, PloS one.

[5]  N. Osada,et al.  Vascular Graft Impregnation with Antibiotics: The Influence of High Concentrations of Rifampin, Vancomycin, Daptomycin, and Bacteriophage Endolysin HY-133 on Viability of Vascular Cells , 2017, Medical science monitor basic research.

[6]  L. Buja,et al.  Prevention of perioperative vascular prosthetic infection with a novel triple antimicrobial-bonded arterial graft. , 2016, Journal of vascular surgery.

[7]  R. Burgkart,et al.  Silver nanoparticle-enriched diamond-like carbon implant modification as a mammalian cell compatible surface with antimicrobial properties , 2016, Scientific Reports.

[8]  L. Bordenave,et al.  Comparison of the Antimicrobial Properties of Silver Impregnated Vascular Grafts with and without Triclosan. , 2016, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[9]  Jarosław Witkowski,et al.  Polymers as Carriers of Gentamicin in Traumatology and Orthopedic Surgery - Current State Of Knowledge. , 2016, Polimery w medycynie.

[10]  R. Schmid,et al.  Microbial Colonization of Pancreatic Duct Stents: A Prospective Analysis , 2015, Pancreas.

[11]  P. Gloviczki,et al.  Treatment strategies and outcomes in patients with infected aortic endografts. , 2013, Journal of vascular surgery.

[12]  A. Haverich,et al.  Prevention of vascular graft infections with antibiotic graft impregnation prior to implantation: in vitro comparison between daptomycin, rifampin and nebacetin. , 2012, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[13]  M. H. Young,et al.  Vascular graft infections. , 2012, Infectious disease clinics of North America.

[14]  P. Devos,et al.  Vascular graft infections in the intensive care unit: clinical spectrum and prognostic factors. , 2011, The Journal of infection.

[15]  D. Janczak,et al.  In situ revascularisation with silver-coated polyester prostheses and arterial homografts in patients with aortic graft infection--a prospective, comparative, single-centre study. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[16]  F. Audebert,et al.  Microbial Spectrum and Primary Resistance to Rifampicin in Infectious Complications in Vascular Surgery: Limits to the Use of Rifampicin-Bonded Prosthetic Grafts , 2010, Angiology.

[17]  N. Jakovljević,et al.  Dacron or ePTFE graft for above-knee femoropopliteal bypass reconstruction. A bi-centre randomised study. , 2010, VASA. Zeitschrift fur Gefasskrankheiten.

[18]  G. Ginalska,et al.  Vascular prostheses with covalently bound gentamicin and amikacin reveal superior antibacterial properties than silver-impregnated ones--an in vitro study. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[19]  E. Debus,et al.  Prophylactic use of the silver-acetate-coated graft in arterial occlusive disease: a retrospective, comparative study. , 2009, Journal of vascular surgery.

[20]  M. Back,et al.  Evolving Microbiology and Treatment of Extracavitary Prosthetic Graft Infections , 2009, Vascular and endovascular surgery.

[21]  P. Coene,et al.  Local gentamicin reduces perineal wound infection after radiotherapy and abdominoperineal resection , 2008, Techniques in Coloproctology.

[22]  R. Hassen-Khodja,et al.  In-situ revascularisation for patients with aortic graft infection: a single centre experience with silver coated polyester grafts. , 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[23]  J. Lindholt,et al.  Laparoscopic diagnosis and treatment of aortic vascular prosthetic graft infections in a porcine model. , 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[24]  D. Bandyk.  Vascular surgical site infection: risk factors and preventive measures. , 2008, Seminars in vascular surgery.

[25]  M. Tripodi,et al.  Infection of intravascular prostheses: how to treat other than surgery. , 2007, International journal of antimicrobial agents.

[26]  H. Turgut,et al.  Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. , 2007, The Journal of surgical research.

[27]  C. Edmiston,et al.  Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices. , 2006, American journal of surgery.

[28]  Peter Andrew,et al.  A systematic review and meta-analysis of treatments for aortic graft infection. , 2006, Journal of vascular surgery.

[29]  H. Turgut,et al.  The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study. , 2005, The Journal of surgical research.

[30]  K. Tekin,et al.  Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidis graft infection , 2005, BMC infectious diseases.

[31]  B. Söderquist,et al.  Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. , 2005, The Annals of thoracic surgery.

[32]  M. Nicolas-Chanoine,et al.  Comparison of the resistance to infection of rifampin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses. , 2002, Journal of vascular surgery.

[33]  G. Torsello,et al.  Systemic and local antibiotic prophylaxis in the prevention of prosthetic vascular graft infection: an experimental study. , 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[34]  A Odero,et al.  Vascular prosthetic Graft Infection: Epidemiology, Bacteriology, Pathogenesis and Treatment , 2002, Acta chirurgica Belgica.

[35]  M. Back,et al.  Expanded application of in situ replacement for prosthetic graft infection. , 2001, Journal of vascular surgery.

[36]  J. Earnshaw,et al.  The current role of rifampicin-impregnated grafts: pragmatism versus science. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[37]  J. Seeger.  Management of Patients with Prosthetic Vascular Graft Infection , 2000, The American surgeon.

[38]  R. Sayers,et al.  In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998) , 1999 .

[39]  J. Earnshaw,et al.  Early results of a randomized trial of rifampicin‐bonded Dacron grafts for extra‐anatomic vascular reconstruction , 1998, The British journal of surgery.

[40]  A. Freyrie,et al.  The rifampicin-bonded gelseal graft. , 1997, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[41]  A. Freyrie,et al.  Prophylaxis of Graft Infection with Rifampicin-Bonded Gelseal Graft: 2-Year Follow-Up of a Prospective Clinical Trial , 1996 .

[42]  A. Freyrie,et al.  Prophylaxis of graft infection with rifampicin-bonded Gelseal graft: 2-year follow-up of a prospective clinical trial. Italian Investigators Group. , 1996, Cardiovascular surgery.

[43]  A. Gehrt,et al.  In situ replacement of infected vascular prostheses with rifampin-soaked vascular grafts: early results. , 1993, Journal of vascular surgery.